Medical Complications of Anorexia Nervosa and Bulimia

American Journal of Medicine

Volumn 129, Issue 1, 2016, Pages 30-37

  Westmoreland, Patricia ^a   Krantz, Mori J ^b,c   Mehler, Philip S ^a,b,c  

^a Eating Recovery Center of Denver   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Anorexia nervosa; Bulimia; Hypokalemia; Medical complications; Osteoporosis

Indexed keywords

LAXATIVE;

ANOREXIA NERVOSA; BULIMIA; COMORBIDITY; DISEASE ASSOCIATION; DRUG ABUSE; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; LUNG COMPLICATION; MUSCULOSKELETAL DISEASE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; VOMITING;

EID: 85013306268     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.06.031     Document Type: Review

References (122)

1. 1 Sullivan, P.F., Mortality in anorexia nervosa. Am J Psychiatry 152 (1995), 1073–1074.
2. 2 Harris, E.C., Barraclough, B., Excess mortality of mental disorder. Br J Psychiatry 173 (1999), 11–53.
3. 3 Emborg, C., Mortality and causes of death in eating disorders in Denmark 1970-1993: a case register study. Int J Eat Disord 25 (1999), 243–251.
4. 4 Nielsen, S., Epidemiology and mortality of eating disorders. Psychiatr Clin North Am 24 (2001), 201–214.
5. 5 Mehler, P.S., Krantz, M., Anorexia nervosa medical issues. J Womens Health 12 (2003), 331–340.
6. 6 Guarda, A.S., Treatment of anorexia nervosa: insights and obstacles. Physiol Behav 94 (2008), 113–120.
7. 7 Herpertz-Dahlmann, B., Adolescent eating disorders: definitions, symptomatology, epidemiology and comorbidity. Child Adolesc Psychiatr Clin N Am 18 (2009), 31–47.
8. 8 Crow, S.J., Peterson, C.B., Swanson, S.A., et al. Increased mortality in bulimia nervosa and other eating disorders. Am J Psychiatry 166 (2009), 1342–1346.
9. 9 American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Publishing, Arlington, VA, 338–345.
10. 10 Andersen, A., Yager, J., Eating disorders. Saddock, B.J., Saddock, V.A., (eds.) Kaplan and Saddock's Comprehensive Textbook of Psychiatry, 8th ed., 2005, Lippincott, Williams and Wilkins, Philadelphia, 2002–2021.
11. 11 Lulé, D., Schulze, U.M.E., Bauer, K., et al. Anorexia nervosa and its relation to depression, anxiety, alexithymia and emotional processing deficits. Eat Weight Disord 19 (2014), 209–216.
12. 12 Kaye, W.H., Fudge, J.L., Paulus, M., New insight into symptoms and neurocircuit function in anorexia nervosa. Nat Rev Neurosci 10 (2009), 573–584.
13. 13 Zink, C.F., Weinberger, D.R., Cracking the moody brain: the rewards of self- starvation. Nat Med 16 (2010), 1382–1383.
14. 14 Pollice, C., Kaye, W.H., Greeno, C.G., Weltzin, T.E., Relationship of depression, anxiety and obsessionality to state of illness in anorexia nervosa. Int J Eat Disord 21 (1997), 367–376.
15. 15 McAdams, C.J., Krawczyk, D.C., Impaired neuronal processing of social attribution in anorexia nervosa. Psych Res 194 (2011), 57–63.
16. 16 Neufang, S., Specht, K., Hausman, M., et al. Sex differences and the impact of steroid hormones on the developing human brain. Cereb Cortex 19 (2009), 464–473.
17. 17 Rothemund, Y., Buchald, C., Georgiewa, P., et al. Compulsivity predicts fronto striatal activation in severely anorectic individuals. Neuroscience 197 (2011), 242–250.
18. 18 Bühren, K., Schwarte, R., Fluck, N., et al. Comorbid psychiatric disorders in female adolescents with first-onset anorexia nervosa. Eur Eat Disorders Rev 22 (2013), 39–44.
19. 19 Aspen, V., Weisman, H., Nafiz, N., et al. Psychiatric comorbidity in women presenting across the continuum of disordered eating. Eat Behav 15 (2014), 686–693.
20. 20 Hudson, J.L., Hiripi, E., Pope, H.G. Jr., Kessler, R.C., The prevalence and correlates of Eating Disorders in the National Comorbidity Survey Replication. Biol Psychiatry 61 (2007), 348–358.
21. 21 Swanson, S.A., Crow, S.J., LeGrange, D., et al. Prevalence and correlates of eating disorders in adolescents. Correlates from the national comorbidity survey. Replication adolescent survey. Arch Gen Psychiatry 68 (2011), 714–723.
22. 22 Brown, T.A., Haedt-Matt, A.A., Keel, P.K., Personality pathology in purging disorder and bulimia nervosa. Int J Eat Disord 44 (2011), 735–740.
23. 23 Rossiter, E.M., Agras, W.S., Telch, C.F., Schneider, J.A., Cluster B personality disorder characteristics predict outcome in patients with bulimia nervosa. Int J Eat Disord 13 (1993), 349–357.
24. 24 Herzog, T.A., Hartmann, A., Sandholz, A., Stammer, H., Prognostic factors in outpatient therapy of bulimia. Psychother Psychosom 56 (1991), 48–55.
25. 25 Button, E.J., Chadalavada, B., Palmer, R.L., Mortality and predictors of death in a cohort of patients presenting to an eating disorders service. Int J Eat Disord 43 (2010), 387–392.
26. 26 Franko, D.L., Keel, P.K., Dorer, D.J., et al. What predicts suicide attempts in women with eating disorders?. Psychol Med 34 (2004), 843–853.
27. 27 Keel, P.K., Dorer, D.J., Eddy, K.T., et al. Predictors of mortality in eating disorders. Arch Gen Psychiatry 60 (2003), 179–183.
28. 28 Papadopoulos, F.C., Ekbom, A., Brandt, L., et al. Excess mortality, causes of death and prognostic factors in anorexia nervosa. Br J Psychiatry 194 (2009), 10–17.
29. 29 Raykos, B.C., McEvoy, P.M., Carter, O., Fursland, A., Nathan, P., Interpersonal problems across restrictive and binge-purge samples: data from a community-based eating disorders clinic. Eat Behav 15 (2014), 449–452.
30. 30 Atiye, M., Miettunen, J., Raevuori-Helkamaa, A., A meta-analysis of temperament in eating disorders. Eur Eat Disord Rev 23 (2015), 88–99.
31. 31 Brauhardt, A., de Zwaan, M., Hilbert, A., The therapeutic process in psychological treatments for eating disorders: a systematic review. Int J Eat Disord 47 (2014), 565–584.
32. 32 Yager, J., Devlin, M.J., Halmi, K.A., et al. Practice Guideline for the Treatment of Patients with Eating Disorders. 3rd ed., 2006, American Psychiatric Association, Washington, DC.
33. 33 Kaye, W.H., Nagata, T., Weltzin, T.E., et al. Double-blind placebo controlled administration of fluoxetine in restricting and purging type anorexia nervosa. Biol Psychiatry 49 (2001), 644–652.
34. 34 Walsh, B.T., Kaplan, A.S., Attia, E., et al. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA 295 (2006), 2605–2612.
35. 35 deVos, J., Houtzager, L., Katsaragaki, G., et al. Meta-analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa. J Eat Disord, 2, 2014, 27.
36. 36 Kaye, W.H., Frank, G.K., Bailer, U.F., Henry, S.E., Neurobiology of anorexia nervosa: clinical implications of alterations of the function of serotonin and other neuronal systems. Int J Eat Disord 37 (2005), S15–S19.
37. 37 Hay, P.J., Claudino, A.M., Clinical psychopharmacology of eating disorders: a research update. Int J Neuropsychopharmacol 15 (2012), 209–222.
38. 38 Flament, M.F., Bissada, H., Spettigue, W., Evidence-based pharmacotherapy of eating disorders. In J Neuropsychopharmacol 15 (2012), 189–207.
39. 39 McKnight, R.F., Park, R.J., Atypical antipsychotics and eating disorders: a review. Eur Eat Disord Rev 18 (2010), 10–21.
40. 40 Kishi, T., Kafantaris, V., Sunday, S., et al. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis. J Clin Psychiatry 73 (2012), e757–e766.
41. 41 Goldstein, D.J., Wilson, M.G., Ashcroft, R.C., et al. Effectiveness of pharmacotherapy in bulimia nervosa regardless of comorbid depression. Int J Eat Disord 25 (1999), 19–27.
42. 42 Walsh, B.T., Agras, W.S., Devlin, M.J., et al. Fluoxetine for bulimia nervosa following poor response to psychotherapy. Am J Psychiatry 157 (2000), 1332–1334.
43. 43 Serpell, S., Stobie, B., Fairburn, C.G., et al. Empirically-supported and non-empirically supported therapies for bulimia nervosa: retrospective patient ratings. J Eat Disord, 1, 2013, 41.
44. 44 Gaudiani, J.L., Braverman, J.M., Mascolo, M., Mehler, P.S., Lagophthalmos in severe anorexia nervosa: a case study. Arch Ophthalmol 130 (2012), 928–930.
45. 45 Holmes, S.R., Gudridge, T.A., Gaudiani, J.L., Mehler, P.S., Dysphagia in severe anorexia nervosa: a case report. Int J Eat Disord 45 (2012), 463–466.
46. 46 Benini, L., Todesco, T., Dalle Grave, R., Deiorio, F., Salandini, L., Vantini, I., Gastric emptying in patients with restricting and binge/purging subtypes of anorexia nervosa. Am J Gastroenterol 99 (2004), 1448–1454.
47. 47 Mascolo, M., Dee, E., Townsend, R., Brinton, J.T., Mehler, P.S., Severe gastric dilatation due to superior mesenteric artery syndrome in anorexia nervosa. Int J Eat Disord 48 (2015), 532–534.
48. 48 Welsch, T., Buchler, M.W., Kienle, P., Recalling superior mesenteric artery syndrome. Dig Surg 24 (2007), 149–156.
49. 49 Le Moigne, F., Lamboley, J.L., Vitry, T., et al. Superior mesenteric artery syndrome: a rare etiology of upper intestinal obstruction in adults. Gastroenterol Clin Biol 34 (2010), 403–406.
50. 50 Zipfel, S., Sammet, I., Rapps, N., Herzog, W., Herpertz, S., Martens, U., Gastrointestinal disturbances in eating disorders: a clinical and neurobiological aspects. Auton Neurosci 129 (2006), 99–106.
51. 51 Miller, K.K., Grinspoon, S.K., Ciampa, J., Hier, J., Herzog, D., Klibanski, A., Medical findings in outpatients with anorexia nervosa. Arch Intern Med 165 (2005), 561–566.
52. 52 De Caprio, C., Alfano, A., Senatore, I., Zarrella, L., Pasanisi, F., Contaldo, F., Severe acute liver damage in anorexia nervosa: two case reports. Nutrition 22 (2006), 572–575.
53. 53 Brown, C.A., Sabel, A.L., Gaudiani, J.L., Mehler, P.S., Predictors of hypophosphatemia during refeeding of patients with severe anorexia nervosa. Int J Eat Disord, 2015 Apr 2 [Epub ahead of print].
54. 54 Narayanan, V., Gaudiani, J.L., Harris, R.H., Mehler, P.S., Liver function test abnormalities in anorexia nervosa – cause or effect. Int J Eat Disord 43 (2010), 378–381.
55. 55 Arnette, E.N., Isner, J.M., Redwood, D.R., et al. Coronary artery narrowing in coronary heart disease: a comparison of cineangiographic and necropsy findings. Ann Intern Med 91 (1979), 350–356.
56. 56 Yahalom, M., Spitz, M., Sandler, L., Heno, N., Roguin, N., Turgeman, Y., The significance of bradycardia in anorexia nervosa. Int J Angiol 22 (2013), 83–94.
57. 57 Krantz, M.J., Gaudianni, J., Johnson, V., Mehler, P.S., Exercise electrocardiography extinguishes persistent junctional rhythm in a patient with severe anorexia nervosa. Cardiology 120 (2011), 217–220.
58. 58 Kossaify, A., Management of sinus node dysfunction with junctional escape rhythm in a case of anorexia nervosa. Turk Kardiyol Dern Ars 38 (2010), 486–488.
59. 59 Krantz, M.J., Sabel, A., Sagar, U., et al. Factors influencing QT prolongation in hospitalized patients with severe anorexia nervosa. Gen Hosp Psychiatry 34 (2011), 173–177.
60. 60 Facchini, M., Sala, L., Malfatto, G., Bragato, R., Redaelli, G., Invitti, C., Low-K+ dependent QT prolongation and risk for ventricular arrhythmia in anorexia nervosa. Int J Cardiol 106 (2006), 170–176.
61. 61 Oflaz, S., Yucel, B., Oz, F., et al. Assessment of myocardial damage by cardiac MRI in patients with anorexia nervosa. Int J Eat Disord 46 (2013), 862–866.
62. 62 Lamzabi, I., Syed, S., Reddy, V.B., Jain, R., Harbhajanka, A., Arunkumar, P., Myocardial changes in a patient with anorexia nervosa: a case report and review of literature. Am J Clin Pathol 143 (2015), 734–737.
63. 63 Gardini, G.G., Boni, E., Todisco, P., Respiratory function in patients with anorexia nervosa. Chest 136 (2009), 1356–1360.
64. 64 Biffl, W., Narayanan, V., Gaudiani, J.L., Mehler, P.S., The management of pneumothorax in patients with anorexia nervosa. Patient Saf Surg 4 (2010), 1–4.
65. 65 Hutter, G., Ganepola, S., Hofmann, W.K., The hematology of anorexia nervosa. Int J Eat Disord 42 (2009), 293–300.
66. 66 Muhajir, M., Gelatinous transformation of bone marrow in a patient with anorexia nervosa. Int J Hematol 97 (2013), 157–158.
67. 67 Nova, E., Samartin, S., Gomez, S., Morande, G., Marcos, A., The adaptive response of the immune system to the particular malnutrition of eating disorders. Eur J Clin Nutr 56 (2002), S34–37.
68. 68 Brown, R.F., Bartrop, R., Beaumont, P., Birmingham, C.L., Bacterial infections in anorexia nervosa: delayed recognition increases complication. Int J Eat Disord 37 (2005), 261–265.
69. 69 Sabel, A., Gaudiani, J., Statland, B., Mehler, P.S., Hematological abnormalities in severe anorexia nervosa. Ann Hematol 92 (2013), 605–609.
70. 70 Corbetta, F., Tremolizzo, L., Conti, E., et al. Paradoxical increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa. Int J Eat Disord 48 (2015), 317–322.
71. 71 Kraeft, J.J., Uppot, R.N., Heffess, A.M., Imaging findings in anorexia nervosa. AJR Am J Roentgenol 200 (2013), 328–334.
72. 72 Faje, A.T., Fazeli, P.K., Miller, K.K., et al. Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord 47 (2014), 458–466.
73. 73 Vestergaard, P., Emborg, C., Stovving, R.K., Hagen, C., Moseklide, L., Brixen, K., Fractures in patients with anorexia nervosa – a nationwide register study. Int J Eat Disord 32 (2002), 301–308.
74. 74 Miller, K.K., Lee, E.E., Lawson, E.A., et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 91 (2011), 2931–2937.
75. 75 Klibanski, A., Biller, B.M., Schoenfeld, D.A., Herzog, D.B., Saxe, V.C., The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80 (1995), 898–904.
76. 76 Stokosh, G.R., Friedman, A.J., Wu, S.C., Kamin, M., Effects of oral contraceptive on bone mineral density in adolescent females with anorexia nervosa. J Adolesc Health 39 (2006), 819–827.
77. 77 Golden, N.H., Lanzkowsky, L., Schebendach, J., Palestro, C.J., Jacobson, M.S., Shenker, I.R., The effect of estrogen progestin treatment on bone density in anorexia nervosa. J Pediatr Adolesc Gynecol 15 (2002), 135–143.
78. 78 Misra, M., Katzman, D., Miller, K.K., et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 26 (2011), 2430–2438.
79. 79 Mehler, P.S., Mackenzie, T.D., Treatment of osteopenia and osteoporosis in anorexia nervosa. A systematic review of the literature. Int J Eat Disord 42 (2009), 195–201.
80. 80 Golden, N.H., Iglesias, E.A., Jacobson, M.S., et al. Alendronate for the treatment of osteopenia in anorexia nervosa. J Clin Endocrinol Metab 90 (2005), 3179–3184.
81. 81 Fazeli, P.K., Wang, I.S., Miller, K.K., et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab 99 (2014), 1322–1329.
82. 82 Zaher, S., LeBoff, M., Lewiecki, M., Denosumab for the treatment of osteoporosis. Expert Opin Drug Metab Toxicol 11 (2015), 461–470.
83. 83 Mehler, P.S., Sabel, A.L., Watson, T., Andersen, A.E., High risk of osteoporosis in male patients with eating disorders. Int J Eat Disord 41 (2008), 666–672.
84. 84 Devlin, M.J., Walsh, B.T., Katz, J.L., et al. Hypothalamic-pituitary-gonadal function in anorexia nervosa. Psychiatry Res 28 (1989), 11–16.
85. 85 Miller, K.K., Grinspoon, S., Gleysteen, S., et al. Preservation of neuroendocrine control of reproductive function despite under nutrition. J Clin Endocrinol Metab 89 (2004), 4434–4438.
86. 86 Golden, N.H., Jacobson, M.S., Schebendach, J., et al. Presumption of menses in anorexia nervosa. Adolesc Med 151 (1997), 16–21.
87. 87 Jocangeli, F., Masala, S., Staar Mezzasalma, F., et al. Amenorrhea after weigh recovery in anorexia nervosa: role of body composition and endocrine abnormalities. Eat Weight Disord 11 (2006), e20–26.
88. 88 Lo Sauro, C., Ravaldi, C., Cabras, P.L., et al. Stress, hypothalamic-pituitary-adrenal axis and eating disorders. Neuropsychobiology 57 (2008), 95–100.
89. 89 Golden, N.H., Kreitzer, P., Jacobson, M.S., et al. Disturbance in growth hormone secretion and action in adolescents with anorexia nervosa. J Pediatr 125 (1994), 655–660.
90. 90 Utiger, R.D., Altero thyroid function in non-thyroidal illness and surgery. To treat or not to treat. N Engl J Med 333 (1995), 1562–1567.
91. 91 Rich, L.M., Caine, M.R., Findling, J.W., Shader, J.L., Hypoglycemic coma in anorexia nervosa. Arch Intern Med 150 (1990), 894–898.
92. 92 Baechle, C., Castillo, K., Strasburger, K., Is disordered eating behavior more prevalent in adolescents with type 1 diabetes then in their respective peers?. Int J Eat Disord 47 (2014), 342–352.
93. 93 Wisting, L., Frossland, D.H., Skrivarhaug, T., Dahl-Jorgenson, K., Ro, O., Disturbed eating behavior and commission of insulin in adolescents receiving insulin treatment. Diabetes Care 36 (2013), 3382–3387.
94. 94 Roberto, C.A., Mayer, L.E., Brickman, A.M., et al. Brain tissue volume changes following weight gain in anorexia nervosa. Int J Eat Disord 44 (2011), 406–410.
95. 95 Strumia, R., (eds.) Eating Disorders and the Skin, 2012, Springer Publishing Company, New York.
96. 96 Denholm, M., Jankowski, J., Gastroesophageal reflux disease and bulimia nervosa—a review of the literature. Dis Esophagus 24 (2011), 79–85.
97. 97 Dessureault, S., Coppola, D., Weitzner, M., Powers, P., Karl, R.C., Barrett's esophagus and squamous cell carcinoma in a patient with psychogenic vomiting. Int J Gastrointest Cancer 32 (2002), 57–61.
98. 98 Spechler, S.J., Souza, R.F., Barrett's esophagus. N Engl J Med 371 (2014), 836–845.
99. 99 Uhlen, M.M., Tveit, A.B., Stenhagen, K.R., Mulic, A., Self-induced vomiting and dental erosion–a clinical study. BMC Oral Health, 14, 2014, 92.
100. 100 Christensen, G.J., Oral care for patients with bulimia. J Am Dent Assoc 133 (2002), 1689–1691.
101. 101 Ferreira, C.P., Gama, A.C., Santos, M.A., Maia, M.O., Laryngeal and vocal analysis in bulimic patients. Braz J Otorhinolaryngol 76 (2010), 469–477.
102. 102 Coleman, H., Altini, M., Nayler, S., Richards, A., Sialadenosis: a presenting sign in bulimia. Head Neck 20 (1998), 758–762.
103. 103 Kinzl, J., Biebl, W., Herold, M., Significance of vomiting for hyperamylasemia and sialadenosis in patients with eating disorders. Int J Eat Disord 13 (1993), 117–124.
104. 104 Mehler, P.S., Wallace, J.A., Sialadenosis in bulimia: a new treatment. Arch Otolaryngol Head Neck Surg 119 (1993), 787–788.
105. 105 Bahia, A., Mascolo, M., Gaudiani, J.L., Mehler, P.S., PseudoBartter syndrome in eating disorders. Int J Eat Disord 45 (2012), 150–153.
106. 106 Trent, S.A., Moreira, M.E., Colwell, C.B., Mehler, P.S., ED management of patients with eating disorders. Am J Emerg Med 31 (2013), 859–865.
107. 107 Mascolo, M., Trent, S., Colwell, C., Mehler, P., What the emergency room department needs to know when caring for patients with eating disorders. Int J Eat Disord 45 (2012), 977–981.
108. 108 Wolfe, B.E., Metzger, E.D., Levine, J.M., Jimerson, D.C., Laboratory screening for electrolyte abnormalities in bulimia nervosa. Int J Eat Disord 30 (2001), 288–293.
109. 109 Jensen, H.K., Brabrand, M., Vinholt, P.J., Hallas, J., Lassen, A.T., Hypokalemia in acute medical patients: risk factors and prognosis. Am J Med 128 (2015), 60–67.
110. 110 Silber, T.J., Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?. J Adolesc Health 37 (2005), 256–260.
111. 111 Ho, P.C., Dweik, R., Cohen, M.C., Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clin Cardiol 21 (1998), 780–783.
112. 112 Koracs, D., Palmer, R.L., The association between laxative abuse and other symptoms among adults with anorexia nervosa. Int J Eat Disord 36 (2004), 224–228.
113. 113 Xing, J.H., Soffer, E.E., Adverse effects of laxatives. Dis Colon Rectum 44 (2001), 1201–1209.
114. 114 Malik, M., Stratton, J., Sweeney, W.B., Rectal prolapse associated with bulimia nervosa: report of seven cases. Dis Colon Rectum 40 (1997), 1382–1385.
115. 115 Dukas, L., Willett, W.C., Colditz, G.A., Fuchs, C.S., Rosner, B., Giovannucci, E.L., Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol 151 (2000), 958–964.
116. 116 Muller-Lissner, S., What has happened to the cathartic colon?. Gut 39 (1996), 486–488.
117. 117 Smith, B., Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut 9 (1968), 139–143.
118. 118 Joo, J.S., Ehrenpreis, E.D., Gonzalez, L., et al. Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J Clin Gastroenterol 26 (1998), 283–286.
119. 119 Colton, P., Woodside, D.B., Kaplan, A.S., Laxative withdrawal in eating disorders. Treatment protocol and 3 to 20 year follow up. Int J Eat Disord 25 (1997), 311–317.
120. 120 Chu, E.S., Gaudiani, J.L., Mascolo, M., et al. ACUTE center for eating disorders. J Hosp Med 7 (2012), 340–344.
121. 121 Davies, C., The use of phosphate enemas in the treatment of constipation. Nurs Times 100 (2004), 32–35.
122. 122 Ori, Y., Rozen-Zoi, B., Chagnac, A., Fatalities and severe metabolic disorders associated with the use of sodium phosphate enemas. Arch Intern Med 172 (2012), 263–265.